July 31, 2026 - Privacy, Security & Regulatory Landscape / Measuring Impact & Value

July 31, 2026

Session A: Privacy, Security & Regulatory Landscape

Goal: Ensure compliance and risk awareness 

  • HIPAA and AI                                                                 
  • De-identification and re-identification risks
  • FDA regulation of AI/ML medical devices
  • Clinical decision support vs regulated devices
  • Model updates and regulatory implications
  • Data sharing and vendor contracts

Key takeaway: Regulation is evolving—risk management is essential

Session B: Measuring Impact & Value

Goal: Focus on outcomes, not novelty                                                                   

  • Clinical outcomes vs process metrics                                                       
  • Cost, efficiency, and ROI
  • Patient experience considerations
  • Continuous improvement cycles
  • When to retire or replace AI tools

Target Audience

This activity is intended for physicians, nurses, quality & safety professionals, healthcare administrators & pharmacists.

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Develop a shared AI vocabulary and conceptual foundation
  2. Describe the data that powers AI systems and identify their limitations
  3. Relate core AI concepts to real‑world clinical and operational workflows
  4. Describe the value of AI within and beyond direct clinical care
  5. Critically assess AI tools for appropriateness, performance, and risk
  6. Apply principles that ensure safe and equitable use of AI
  7. Integrate appropriate trust in, and adoption of, AI-enabled tools
  8. Identify rapidly emerging AI tools that clinicians are already using
  9. Measure the impact and value of AI tools in healthcare settings
  10. Integrate AI use with standards of clinical professionalism

Additional Information

Provided by: 

Center for AI and Biomedical Informatics in a Learning Health System (CAIBILS) & Mass General Brigham
image

Course summary
Course opens: 
05/01/2026
Course expires: 
09/28/2026
Event starts: 
07/31/2026 - 12:00pm EDT
Event ends: 
07/31/2026 - 2:00pm EDT
Cost:
$0.00

Speakers

Jonathan Einbinder, MD, MPH
Professor of Medicine, Harvard Medical School
Vice President of Advanced Data Analytics and Coding, CRICO

Kourosh Ravvaz, MD, PhD
Senior Data Scientist, Mass General Brigham Digital
Lecturer, Division of General Internal Medicine, Department of Medicine, Harvard Medical School

Course Co-Directors

David W. Bates, MD, MSc
Director, Center for Artificial Intelligence and Bioinformatics in the Learning Healthcare System (CAIBILS), Mass General Brigham
Professor of Medicine, Harvard Medical School

Hossein Estiri, PhD
Investigator, Massachusetts General Hospital
Associate Professor of Medicine, Harvard Medical School

Li Zhou, MD, PhD
Director, MTERMS Lab, Mass General Brigham
Lead Investigator, Brigham and Women’s Hospital
Professor of Medicine, Harvard Medical School

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 CreditsTM
Mass General Brigham designates this live activity for a maximum of 26.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing
Mass General Brigham designates this activity for 26.00 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.

Pharmacy
This activity provides 26.00 contact hours (26.00 CEUs) of continuing education credit. ACPE Universal Activity Number (UAN): JA0007437-0000-26-008-L99-P

Price

Cost:
$0.00
Please login or register to take this course.